| Literature DB >> 28660800 |
Neal M Lonky1, Yasmina Mohan2, Vicki Y Chiu2, Jeanna Park3,4, Seth Kivnick5, Christina Hong1, Sharon M Hudson2.
Abstract
OBJECTIVE: To examine variables associated with hysterectomy-related complications, relative to surgical approach and other variables, that lead to readmission within 90 days of surgery.Entities:
Keywords: complications; hysterectomy; readmission
Mesh:
Year: 2017 PMID: 28660800 PMCID: PMC5557180 DOI: 10.1177/1745505717714657
Source DB: PubMed Journal: Womens Health (Lond) ISSN: 1745-5057
Patient characteristics by hysterectomy route.
| Hysterectomy route | ||||||||
|---|---|---|---|---|---|---|---|---|
| LAVH (N = 740) | LSH (N = 494) | SAH (N = 90) | TAH (N = 489) | TLH (N = 706) | TVH (N = 587) | Total (N = 3106) | p-value | |
| Age (years) | <.001 | |||||||
| Mean (SD) | 47.6 (9.7) | 46.0 (6.7) | 45.7 (5.7) | 48.9 (9.8) | 48.0 (8.9) | 53.0 (12.1) | 48.6 (9.8) | |
| Age (years) | <.001 | |||||||
| 25–39 | 118 (15.9%) | 62 (12.6%) | 9 (10.0%) | 63 (12.9%) | 93 (13.2%) | 76 (12.9%) | 421 (13.6%) | |
| 40–49 | 378 (51.1%) | 317 (64.2%) | 64 (71.1%) | 245 (50.1%) | 365 (51.7%) | 179 (30.5%) | 1548 (49.8%) | |
| 50–59 | 156 (21.1%) | 93 (18.8%) | 16 (17.8%) | 119 (24.3%) | 168 (23.8%) | 154 (26.2%) | 706 (22.7%) | |
| 60–69 | 63 (8.5%) | 18 (3.6%) | 1 (1.1%) | 42 (8.6%) | 55 (7.8%) | 114 (19.4%) | 293 (9.4%) | |
| 70+ | 25 (3.4%) | 4 (0.8%) | 0 (0%) | 20 (4.1%) | 25 (3.5%) | 64 (10.9%) | 138 (4.4%) | |
| Race/ethnicity | <.001 | |||||||
| White | 286 (38.6%) | 108 (21.9%) | 18 (20.0%) | 147 (30.1%) | 266 (37.7%) | 240 (40.9%) | 1065 (34.3%) | |
| Hispanic | 291 (39.3%) | 170 (34.4%) | 32 (35.6%) | 190 (38.9%) | 225 (31.9%) | 278 (47.4%) | 1186 (38.2%) | |
| Black | 106 (14.3%) | 175 (35.4%) | 25 (27.8%) | 90 (18.4%) | 144 (20.4%) | 39 (6.6%) | 579 (18.6%) | |
| Asian/Pacific Islander | 49 (6.6%) | 35 (7.1%) | 11 (12.2%) | 55 (11.2%) | 59 (8.4%) | 25 (4.3%) | 234 (7.5%) | |
| Other/unknown | 8 (1.1%) | 6 (1.2%) | 4 (4.4%) | 7 (1.4%) | 12 (1.7%) | 5 (0.9%) | 42 (1.4%) | |
| BMI | <.001 | |||||||
| Mean (SD) | 30.4 (6.5) | 30.3 (6.8) | 32.8 (8.6) | 30.7 (7.3) | 30.0 (6.8) | 28.8 (5.7) | 30.1 (6.7) | |
| BMI | <.001 | |||||||
| <18.5 (under) | 6 (0.8%) | 3 (0.6%) | 1 (1.1%) | 2 (0.4%) | 1 (0.1%) | 6 (1.0%) | 19 (0.6%) | |
| 18.5–24.9 (normal) | 144 (19.5%) | 109 (22.1%) | 18 (20.0%) | 104 (21.3%) | 166 (23.5%) | 144 (24.5%) | 685 (22.1%) | |
| 25.0–29.9 (overweight) | 245 (33.1%) | 155 (31.4%) | 20 (22.2%) | 158 (32.3%) | 225 (31.9%) | 226 (38.5%) | 1029 (33.1%) | |
| 30.0–34.9 (obese class 1) | 179 (24.2%) | 120 (24.3%) | 18 (20.0%) | 107 (21.9%) | 175 (24.8%) | 139 (23.7%) | 738 (23.8%) | |
| 35.0–39.9 (class 2) | 110 (14.9%) | 63 (12.8%) | 16 (17.8%) | 67 (13.7%) | 76 (10.8%) | 48 (8.2%) | 380 (12.2%) | |
| 40+ (class 3) | 56 (7.6%) | 44 (8.9%) | 17 (18.9%) | 51 (10.4%) | 63 (8.9%) | 24 (4.1%) | 255 (8.2%) | |
| Pelvic specimen (g) | <.001 | |||||||
| Mean (SD) | 214.8 (199.5) | 394.0 (433.9) | 712.7 (962.5) | 529.3 (680.7) | 303.2 (418.4) | 113.6 (85.2) | 298.3 (429.3) | |
| Pelvic specimen (g) | <.001 | |||||||
| Missing | 51 (6.9%) | 75 (15.2%) | 57 (63.3%) | 58 (11.9%) | 63 (8.9%) | 51 (8.7%) | 355 (11.4%) | |
| 0–50 | 334 (45.1%) | 139 (28.1%) | 7 (7.8%) | 137 (28%) | 268 (38%) | 419 (71.4%) | 1304 (42.0%) | |
| 151–300 | 220 (29.7%) | 114 (23.1%) | 9 (10.0%) | 91 (18.6%) | 198 (28%) | 93 (15.8%) | 725 (23.3%) | |
| 301–500 | 87 (11.8%) | 68 (13.8%) | 4 (4.4%) | 57 (11.7%) | 83 (11.8%) | 20 (3.4%) | 319 (10.3%) | |
| 501+ | 48 (6.5%) | 98 (19.8%) | 13 (14.4%) | 146 (29.9%) | 94 (13.3%) | 4 (0.7%) | 403 (13%) | |
| Estimated blood loss (mL) | <.001 | |||||||
| Mean (SD) | 184.4 (177.7) | 93.0 (111.3) | 362.1 (315.9) | 333.8 (449.7) | 106.9 (117.4) | 183.0 (149.1) | 180.9 (241.7) | |
| Estimated blood loss (mL) | <.001 | |||||||
| Missing | 27 (3.6%) | 27 (5.5%) | 5 (5.6%) | 30 (6.1%) | 54 (7.6%) | 29 (4.9%) | 172 (5.5%) | |
| 0–50 | 153 (20.7%) | 269 (54.5%) | 6 (6.7%) | 48 (9.8%) | 324 (45.9%) | 73 (12.4%) | 873 (28.1%) | |
| 51–100 | 204 (27.6%) | 115 (23.3%) | 10 (11.1%) | 78 (16%) | 159 (22.5%) | 156 (26.6%) | 722 (23.2%) | |
| 101–200 | 175 (23.6%) | 45 (9.1%) | 25 (27.8%) | 124 (25.4%) | 105 (14.9%) | 199 (33.9%) | 673 (21.7%) | |
| 201–300 | 91 (12.3%) | 17 (3.4%) | 7 (7.8%) | 74 (15.1%) | 41 (5.8%) | 70 (11.9%) | 300 (9.7%) | |
| 301+ | 90 (12.2%) | 21 (4.3%) | 37 (41.1%) | 135 (27.6%) | 23 (3.3%) | 60 (10.2%) | 366 (11.8%) | |
| Total time of surgery (min) | <0001 | |||||||
| Mean (SD) | 142.8 (57.4) | 153.3 (71.3) | 139.4 (54.7) | 134.1 (66.3) | 149.4 (60.4) | 140.1 (72.5) | 144.0 (65.0) | |
| Total time of surgery (h) | <.001 | |||||||
| <1 | 17 (2.3%) | 6 (1.2%) | 2 (2.2%) | 24 (4.9%) | 13 (1.8%) | 59 (10.1%) | 121 (3.9%) | |
| 1–2 | 272 (36.8%) | 179 (36.2%) | 30 (33.3%) | 228 (46.6%) | 225 (31.9%) | 219 (37.3%) | 1153 (37.1%) | |
| 2–3 | 284 (38.4%) | 176 (35.6%) | 41 (45.6%) | 144 (29.4%) | 301 (42.6%) | 157 (26.7%) | 1103 (35.5%) | |
| 3+ | 167 (22.6%) | 133 (26.9%) | 17 (18.9%) | 93 (19%) | 167 (23.7%) | 152 (25.9%) | 729 (23.5%) | |
| Coincident surgery | <.001 | |||||||
| Hysterectomy alone | 310 (41.9%) | 370 (74.9%) | 54 (60.0%) | 176 (36.0%) | 348 (49.3%) | 193 (32.9%) | 1451 (46.7%) | |
| Hysterectomy w/adnexal surgery only | 294 (39.7%) | 92 (18.6%) | 35 (38.9%) | 291 (59.5%) | 315 (44.6%) | 50 (8.5%) | 1077 (34.7%) | |
| Hysterectomy w/combination of adnexal, pelvic, and/or urinary surgeries | 136 (18.4%) | 32 (6.5%) | 1 (1.1%) | 22 (4.5%) | 43 (6.1%) | 344 (58.6%) | 578 (18.6%) | |
| Inpatient length of stay | <.001 | |||||||
| Mean (SD) | 0.9 (1.4) | 0.3 (076) | 3.1 (3.3) | 2.8 (1.5) | 0.4 (0.7) | 1.2 (1.0) | 1.1 (1.5) | |
| Inpatient length of stay | <.001 | |||||||
| 0 | 209 (28.2%) | 362 (73.3%) | 3 (3.3%) | 10 (2.0%) | 494 (70.0%) | 60 (10.2%) | 1138 (36.6%) | |
| 1 | 458 (61.9%) | 111 (22.5%) | 4 (4.4%) | 21 (4.3%) | 167 (23.7%) | 388 (66.1%) | 1149 (37.0%) | |
| 2 | 57 (7.7%) | 17 (3.4%) | 31 (34.4%) | 196 (40.1%) | 33 (4.7%) | 111 (18.9%) | 445 (14.3%) | |
| 3+ | 16 (2.2%) | 4 (0.8%) | 52 (57.8%) | 262 (53.6%) | 12 (1.7%) | 28 (4.8%) | 374 (12.0%) | |
LAVH: laparoscopic-assisted vaginal hysterectomy; LSH: laparoscopic supracervical hysterectomy; SAH: supracervical abdominal hysterectomy; TAH: total abdominal hysterectomy; TLH: total laparoscopic hysterectomy; TVH: total vaginal hysterectomy.
Mean (SD) predictors by surgery type.
| Vaginal (TVH) (N = 587) | Laparoscopic (TLH, LSH, LAVH) (N = 1940) | Abdominal (TAH) (N = 489) | p-value | |
|---|---|---|---|---|
| Pelvic specimen weight (g) | 113.6 (85.2) | 290.1 (360.1) | 529.3 (680.7) | <.001 |
| Estimated blood loss (mL) | 183.0 (149.1) | 133.5 (148.3) | 333.8 (449.7) | <.001 |
| Surgery duration (min) | 140.1 (72.5) | 147.9 (62.4) | 134.1 (66.3) | <.001 |
| Length of stay (24-h period) | 1.2 (1.0) | 0.6 (1.1) | 2.8 (1.5) | <.001 |
TVH: total vaginal hysterectomy; TLH: total laparoscopic hysterectomy; LSH: laparoscopic supracervical hysterectomy; LAVH: laparoscopic-assisted vaginal hysterectomy; TAH: total abdominal hysterectomy.
Readmitted post-operative complications within 90 days of hysterectomy.
| Code | Type | Definition/complications included | Hysterectomy Related | Frequency |
|---|---|---|---|---|
| W | Wound | Seroma, disruption, hematoma, infection | Yes | 14 |
| I | Infection | Other infections related to pelvis or progress to sepsis | Yes | 61 |
| B | Bowel complication | Obstruction, ileus | Yes | 29 |
| PV | Perforated viscus | Bowel, bladder | Yes | 5 |
| BL | Bleeding | Hospitalization or transfusion | Yes | 9 |
| H | Hematoma | Anybody surface or cavity | Yes | 9 |
| C | Cuff/vaginal | Abscess, cellulitis, or dehiscence | Yes | 20 |
| P | Pain management | Yes | 12 | |
| U | Ureteral injury/obstruction | Surgical injury | Yes | 6 |
| V | Vesicovaginal fistula | Pneumonia, deep vein thrombosis | Yes | 3 |
| M | Medical complication | Other surgical episode | No | 32 |
| O | Other | No | 11 | |
| Total | 168 |
Patients with complications that lead to readmission within 90 days of hysterectomy surgery, by independent variables.
| Total[ | Readmitted patients (N = 105) | Non-readmitted patients (N = 2911) | Crude OR (95% CI) | Adjusted OR (95% CI) | |
|---|---|---|---|---|---|
| Age (years) | |||||
| 25–39 | 412 | 20 (4.9%) | 392 (95.1%) | 1.33 (0.93–1.89) | 1.52 (0.91–2.52) |
| 40–49 | 1484 | 55 (3.7%) | 1429 (96.3%) | 1.00 | 1.00 |
| 50–59 | 690 | 19 (2.8%) | 671 (97.2%) | 0.73 (0.51–1.04) | 0.69 (0.39–1.24) |
| 60–69 | 292 | 8 (2.7%) | 284 (97.3%) | 0.73 (0.38–1.43) | 0.82 (0.36–1.89) |
| 70+ | 138 | 3 (2.2%) | 135 (97.8%) | 0.56 (0.24–1.26) | 0.52 (0.14–2.00) |
| Race/ethnicity | |||||
| Non-Hispanic White | 1047 | 31 (3.0%) | 1016 (97.0%) | 1.00 | 1.00 |
| Hispanic | 1154 | 35 (3.0%) | 1119 (97.0%) | 1.07 (0.77–1.50) | 0.89 (0.65–1.23) |
| Black | 554 | 30 (5.4%) | 524 (94.6%) | 2.06 (1.39–3.04) | 1.76 (0.88–3.51) |
| Asian/Pacific Islander | 223 | 8 (3.6%) | 215 (96.4%) | 1.17 (0.69–1.99) | 0.65 (0.31–1.35) |
| Other/unknown | 38 | 1 (2.6%) | 37 (97.4%) | 0.88 (0.17–4.57) | 1.00 (0.18–5.58) |
| BMI | |||||
| <25.0 | 685 | 19 (2.8%) | 666 (97.2%) | 1.00 | 1.00 |
| 25.0–29.9 | 1009 | 35 (3.5%) | 974 (96.5%) | 1.28 (0.89–1.86) | 1.09 (0.68–1.74) |
| 30.0–34.9 | 720 | 26 (3.6%) | 964 (96.4%) | 1.34 (0.83–2.15) | 1.03 (0.60–1.77) |
| 35.0–39.9 | 364 | 16 (4.4%) | 348 (95.6%) | 1.65 (1.02–2.68) | 1.27 (0.69–2.34) |
| 40+ | 238 | 9 (3.8%) | 229 (96.2%) | 1.43 (0.78–2.61) | 0.59 (0.20–1.73) |
| Pelvic specimen weight (g) | |||||
| 0–150 | 1297 | 46 (3.5%) | 1251 (96.5%) | 1.00 | 1.00 |
| 151–300 | 716 | 16 (2.2%) | 700 (97.8%) | 0.62 (0.42–0.91) | 0.40 (0.25–0.64) |
| 301–500 | 315 | 14 (4.4%) | 301 (95.6%) | 1.25 (0.62–2.52) | 0.76 (0.34–1.72) |
| 501+ | 390 | 16 (4.1%) | 374 (95.9%) | 1.15 (0.74–1.79) | 0.54 (0.33–0.90) |
| Estimated blood loss (mL) | |||||
| 0–50 | 867 | 20 (2.3%) | 847 (97.7%) | 1.00 | 1.00 |
| 51–100 | 712 | 24 (3.4%) | 688 (96.6%) | 1.64 (1.16–2.31) | 1.72 (1.16–2.54) |
| 101–200 | 648 | 23 (3.5%) | 625 (96.5%) | 1.73 (0.93–3.23) | 1.59 (0.88–2.86) |
| 201–300 | 293 | 13 (4.4%) | 280 (95.6%) | 2.24 (1.36–3.69) | 2.28 (1.24–4.18) |
| 301+ | 329 | 18 (5.5%) | 311 (94.5%) | 2.81 (1.84–4.31) | 2.63 (1.67–4.14) |
| Surgery duration (h) | |||||
| <2 | 1242 | 36 (2.9%) | 1206 (97.1%) | 1.00 | 1.00 |
| 2–3 | 1062 | 35 (3.3%) | 1027 (96.7%) | 1.12 (0.79–1.59) | 1.16 (0.74–1.83) |
| 3+ | 712 | 34 (4.8%) | 678 (95.2%) | 1.63 (0.98–2.73) | 1.64 (0.81–3.34) |
| Coincident surgery | |||||
| Hysterectomy alone | 1397 | 49 (3.5%) | 1348 (96.5%) | 1.00 | 1.00 |
| Hysterectomy w/adnexal surgery only | 1042 | 43 (4.1%) | 999 (95.9%) | 1.17 (0.74–1.85) | 1.17 (0.51–2.69) |
| Hysterectomy w/combination of adnexal, pelvic, and or urinary surgeries | 577 | 13 (2.3%) | 564 (97.7%) | 0.64 (0.39–1.04) | 0.62 (0.30–1.32) |
| Length of stay (days) | |||||
| 0 | 1135 | 37 (3.3%) | 1098 (96.7%) | 1.00 | 1.00 |
| 1 | 1145 | 35 (3.1%) | 1110 (96.9%) | 1.03 (0.67–1.60) | 1.53 (0.81–2.89) |
| 2 | 414 | 12 (2.9%) | 402 (97.1%) | 0.94 (0.70–1.27) | 1.51 (0.85–2.69) |
| 3+ | 322 | 21 (6.5%) | 301 (93.5%) | 2.16 (1.35–3.43) | 2.93 (1.28–6.69) |
| Hysterectomy procedure[ | |||||
| LAVH | 740 | 11 (1.5%) | 729 (98.5%) | 1.00 | 1.00 |
| LSH | 494 | 16 (3.2%) | 478 (96.8%) | 2.20 (1.40–3.45) | 3.11 (1.13–8.57) |
| TLH | 706 | 38 (5.4%) | 668 (94.6%) | 3.88 (2.57–5.86) | 5.60 (2.90–10.79) |
| TVH | 587 | 16 (2.7%) | 571 (97.3%) | 1.90 (1.18–3.06) | 2.13 (1.15–3.92) |
| TAH | 489 | 24 (4.9%) | 465 (95.1%) | 3.49 (2.60–4.67) | 2.05 (0.88–4.76) |
LAVH: laparoscopic-assisted vaginal hysterectomy; LSH: laparoscopic supracervical hysterectomy; TLH: total laparoscopic hysterectomy; TVH: total vaginal hysterectomy; TAH: total abdominal hysterectomy.
Supracervical abdominal hysterectomy (SAH) cases excluded due to small sample size.